MASCT-CD | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,738 results for “MASCT-CD”

Trials

View all 671 →

Autologous Stem Cell Transplant for Crohn's Disease

50 participants · First posted Jul 17, 2017

Neo-MASCT Immunotherapy for Advanced NSCLC.

20 participants · First posted Jul 2, 2017

MASCT-I Treatment for Advanced Solid Tumor

46 participants · First posted Aug 8, 2016

Drugs

View all 709 →

Neo-MASCT

MASCT-X

MASCT-Ⅰ

Organizations

View all 220 →

CD Acquisitions, LLC

United States

CD Pharma India Pvt. Ltd.

Cantex Mine Development Corp

News

View all 138 →

Stem Cell Transplantation Shows Promise as Myeloid-Directed Cellular Therapy for Refractory Crohn's Disease

CD Biopharma's CD-001 Receives FDA Clearance for Phase 1 Trial in Oncology

Sanofi Enters Talks with CD&R for $16.4B Consumer Health Unit Sale

Page 1 of 174